Saxenda cost at a glance (2026)
| Path | Cost / mo | Best for |
|---|---|---|
| Compounded semaglutide (alternative) | $179 | Switch from Saxenda to weekly compounded |
| Saxenda Savings Card | $25-150 | Commercial insurance + Saxenda preference |
| Wegovy (NovoCare alternative) | $499 | Switch to weekly + greater weight loss |
| Zepbound (LillyDirect alternative) | $399 | Switch to weekly tirzepatide |
| Saxenda retail cash-pay | $1,349 | Almost never the right choice |
Why most patients should consider switching off Saxenda
Saxenda was FDA-approved in 2014 — the first GLP-1 medication for chronic weight management. It remains effective but has been substantially eclipsed by newer weekly-dose GLP-1s:
- Wegovy (semaglutide, 2021): Weekly injection, ~15% mean weight loss vs Saxenda's ~6%
- Zepbound (tirzepatide, 2023): Weekly injection, ~22% mean weight loss
- Daily injection burden: Saxenda requires injection every single day vs once per week for Wegovy/Zepbound
- Cost: All three retail at similar prices ($1,069-1,349); Wegovy/Zepbound have better cash-pay direct programs (NovoCare $499, LillyDirect $399)
For most patients on Saxenda, the conversation with your prescriber should include whether switching to Wegovy or Zepbound is appropriate. Some patients prefer Saxenda (insurance coverage, liraglutide tolerability) and continue successfully — but most patients should at least discuss the alternatives.
Saxenda Savings Card details
The Saxenda Savings Card drops eligible commercially insured patients to $25-150/month (varies by plan). Maximum savings of $200 per fill. Eligibility:
- Commercial (private) insurance that covers Saxenda
- BMI ≥30, or BMI ≥27 with comorbidity
- US resident
- NOT eligible: Medicare, Medicaid, VA, Tricare
Saxenda dose schedule
- Week 1: 0.6mg daily (titration)
- Week 2: 1.2mg daily
- Week 3: 1.8mg daily
- Week 4: 2.4mg daily
- Week 5+: 3.0mg daily (maintenance)
Daily subcutaneous injection in abdomen, thigh, or upper arm. Daily injection is the biggest drawback of Saxenda vs weekly Wegovy/Zepbound — 7x more injection events per week.
FAQ
How much does Saxenda cost in 2026?
Saxenda retail cash-pay is approximately $1,349 for a 28-day supply (one 5-pen carton). With the Saxenda Savings Card, eligible commercially insured patients pay a reduced copay (varies by plan, typically $25-150/month). Saxenda is generally being phased down as Wegovy and Zepbound (newer, more effective GLP-1 medications) have become available — many patients on Saxenda eventually switch.
Is Saxenda being discontinued?
Saxenda is not formally discontinued, but its market share has declined significantly since Wegovy (2021) and Zepbound (2023) launched. Newer weekly-injection medications produce greater weight loss with less frequent dosing. Novo Nordisk continues to support Saxenda with its savings card program. Some patients prefer Saxenda for the daily-dose schedule (vs weekly) or because of insurance coverage requirements.
What's the cheapest alternative to Saxenda?
For most patients seeking weight loss, switching to Zepbound (LillyDirect at $399/month cash-pay) or Wegovy (NovoCare at $499/month) is cheaper than Saxenda retail. With commercial insurance + savings card, all three medications drop to $25-150/month copay. The cheapest cash-pay alternative is compounded semaglutide ($179/month) — same active ingredient as Wegovy, dramatically cheaper than Saxenda.
How does Saxenda compare to Wegovy?
Saxenda (liraglutide) requires daily subcutaneous injection. Wegovy (semaglutide) requires only weekly injection. Wegovy produces significantly greater mean weight loss (~15% vs ~6% for Saxenda over 56-68 weeks). Wegovy is more expensive at retail but comparable with savings cards. For patients prioritizing efficacy + injection frequency, Wegovy is the better choice in 2026. Saxenda is still appropriate for patients with insurance coverage that specifically supports it, or who tolerate liraglutide better than semaglutide.
Is Saxenda covered by Medicare or Medicaid?
Federal law excludes weight-loss medications from Medicare Part D and most Medicaid plans (the same exclusion that affects Wegovy and Zepbound for weight-loss indication). Saxenda for weight loss is not covered. Liraglutide is FDA-approved as Victoza for type 2 diabetes (Medicare-covered), but Saxenda branding is specifically for weight loss and falls under the exclusion.
What's the Saxenda dosing schedule?
Saxenda titrates daily over 5 weeks: 0.6mg (week 1) → 1.2mg (week 2) → 1.8mg (week 3) → 2.4mg (week 4) → 3.0mg (week 5+, maintenance). Each dose level is held for one week. The 3.0mg maintenance dose is the FDA-approved long-term dose. Daily subcutaneous injection in abdomen, thigh, or upper arm.
Are there Patient Assistance Programs (PAPs) for Saxenda?
Yes. Novo Nordisk's Patient Assistance Program covers Saxenda for income-qualified uninsured patients. Application process takes 4-8 weeks. For most uninsured patients, switching to compounded semaglutide ($179/month) is faster than navigating PAP. PAPs remain the right path for patients who specifically need Saxenda and cannot afford retail pricing.
Bottom line on Saxenda cost in 2026
For most patients on Saxenda, the right move in 2026 is to discuss switching to weekly Wegovy or Zepbound for greater weight loss and less frequent injection. With commercial insurance + savings card, all three drop to comparable copay ($25-150/month). For patients who prefer Saxenda or have specific insurance requirements, the savings card path is the cheapest legitimate option.
Find my best GLP-1 path →